JUNIPER: A Randomized Phase 3 Study of Abemaciclib (LY2835219) plus Best Supportive Care versus Erlotinib plus Best Supportive Care in Patients with Stage IV NSCLC with a Detectable KRAS Mutation Who Have Progressed After Platinum-Based Chemotherapy (JPBK)
Projeler > Desteklenmiş Diğer Projeler · 2016
Yazarlar: Tuncay GÖKSEL
2016-2018, Desteklenmiş Diğer Projeler, AR-GE Projesi, Tamamlandı